Skip to main content

Surgery for Chronic Pancreatitis - when medical therapy is not enough.

Frey, Beger, Whipple, total pancreatectomy with islet auto-transplantation - chosen at a pancreas MDT, not by a single surgeon, and never before endoscopic and pain-medicine options have had their turn.

See indicative pricing
A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Indicative pricing

What surgery for chronic pancreatitis costs privately in the UK.

Indicative ranges across our partner units.

In short

£28,000–£45,000, home at 7–10 days.

Service Indicative range
Frey procedure £28,000–£45,000
Beger procedure £32,000–£52,000
Pancreaticoduodenectomy (Whipple) for CP £45,000–£75,000
Total pancreatectomy with islet auto-transplantation £90,000–£160,000
ERCP with stent or stones £2,800–£5,500
EUS-guided intervention £3,500–£7,500
Coeliac plexus block £950–£1,800
HPB and pain-medicine MDT review £850–£1,500

Chronic pancreatitis surgery is usually covered by private medical insurance where the pancreas MDT has agreed the indication. TPIAT normally requires individual funding approval.

The problem

The right patient, the right operation, the right centre.

Chronic pancreatitis surgery works - for a defined subgroup, done in a high-volume centre after a serious non-operative trial. All three matter.

  • Endoscopy first, always

    ERCP for stones and strictures, EUS-guided drainage, coeliac block - before theatre is on the table.

  • Volume matters

    Pancreas surgery outcomes are volume-dependent. High-volume UK centres carry lower mortality and better complication management.

  • The long tail is the operation

    Enzymes, diabetes, nutrition, pain-medicine taper - surgery is only half the plan.

When it helps

The situations where this is the right step.

The situations we see most, plus the red flag that means urgent care rather than a routine appointment.

  • Head-dominant chronic pancreatitis with mass

    A fibrotic mass in the head, dilated duct, and pain not controlled by endoscopy - Frey or Beger territory.

  • Dilated main pancreatic duct >6 mm

    A duct-drainage procedure (Puestow or Frey) offloads pressure - good pain relief in the right anatomy.

  • Suspicion of underlying malignancy

    A mass that cannot be safely called benign belongs in a Whipple pathway, not a hopeful drainage operation.

  • Small-duct disease with intractable pain

    A minority of patients - where drainage will not help - are considered for TPIAT in specialist centres.

  • Complications: pseudocyst, biliary or duodenal obstruction

    Sometimes surgery is for the complication, not the pain - biliary bypass, gastrojejunostomy or drainage.

  • Failed endoscopic therapy

    Multiple ERCPs, stents in and out for years, and still pain - an honest surgical conversation belongs on the table.

  • Alcohol- and smoking-driven disease still active

    Surgery in an actively-drinking or actively-smoking patient rarely pays off. Cessation first, always.

  • Red flag: weight loss, jaundice, new-onset diabetes

    This trio in chronic pancreatitis is pancreatic cancer until proven otherwise - urgent EUS and MDT.

Options

Approach and extent depend on the case.

What each option involves - and where each earns its place.

  • Frey procedure

    Head coring plus lateral pancreaticojejunostomy - decompresses the head and duct in one operation. Workhorse for head-dominant disease with dilated duct.

  • Beger procedure

    Duodenum-preserving pancreatic head resection - preserves upper GI anatomy. Excellent pain relief and endocrine preservation.

  • Pancreaticoduodenectomy (Whipple)

    For head-dominant disease where malignancy cannot be excluded or the mass is extensive. Larger operation, longer recovery, more diabetes risk.

  • Duodenum-preserving pancreatic head resection variants

    Berne modification - a hybrid Beger with fewer anastomoses. Chosen by centre expertise.

  • Distal pancreatectomy

    For tail-dominant disease with a discrete lesion. Less common indication in chronic pancreatitis.

  • Puestow (lateral pancreaticojejunostomy)

    Duct-drainage-only operation for dilated main duct without a head mass - a simpler option in the right anatomy.

  • Total pancreatectomy with islet auto-transplantation (TPIAT)

    For diffuse small-duct disease with intractable pain. Islets are isolated from the removed pancreas and infused into the liver to preserve endogenous insulin.

  • Endoscopic and pain-medicine alternatives

    Not always surgery - ERCP, EUS-guided drainage, coeliac plexus block and structured pain-medicine input are the first line for many.

Our vetted UK network

A small, hand-picked panel of clinicians.

Consultants across London and the major UK cities. Introductions are private once we understand your case.

  • HPB surgeons in high-volume UK centres (specialist pancreas units)

  • Pancreas MDT with gastroenterology, radiology, pain medicine, dietetics

  • Islet isolation laboratory access for TPIAT

  • Structured chronic-pain and addiction support alongside surgery

Safety and recovery

What to expect - honestly.

The things worth planning for, and the red flags that mean same-day care.

  • Major surgery, honest risks

    Pancreas surgery carries mortality of 2–5 percent even in high-volume centres. Morbidity is higher. Chosen only where it will change the trajectory.

  • Pancreatic fistula

    The classic complication. Grades A-C. Most managed with drains; some need re-operation.

  • Delayed gastric emptying

    Common after Whipple, less after Beger and Frey. Usually settles by 2–3 weeks with prokinetics and patience.

  • Bleeding

    Post-op bleeding is a known complication, especially day 3–14. Vigilance and interventional radiology on site matter.

  • Pancreatic exocrine insufficiency

    Enzyme replacement is lifelong after any major pancreas resection - no exceptions, dose titrated to symptoms.

  • Diabetes

    Variable - 0–5 percent after Frey/Beger, 10–20 percent after Whipple. TPIAT preserves endogenous insulin in around 30–70 percent depending on islet yield.

  • Nutrition

    Sarcopenia is common pre-op. Pre-hab (diet, exercise, cessation) improves outcomes measurably. Dietitian input pre- and post-op is standard.

  • Opioid dependence and pain-medicine

    Chronic pancreatitis pain often means chronic opioids. A pain-medicine plan for tapering post-op is agreed in writing pre-op.

  • Red flags after surgery

    Fever with rigors, bright-red drain output, worsening abdominal pain, or new jaundice is same-day team, not a routine call.

Reading your notes

Your report in four parts. Read the last one first.

Whatever the pathway, the summary keeps to the same shape.

  1. 01 Diagnosis

    Disease pattern and indication

    Head-dominant, duct-dilated, small-duct diffuse, malignancy suspicion, or complication-driven. The pattern chooses the operation.

  2. 02 Operation

    Which procedure and why

    Frey, Beger, Whipple, TPIAT, Puestow - the specific operation, anastomoses, drain positions, and any islet isolation.

  3. 03 Complications

    Fistula, bleeding, DGE

    What happened, how it was managed, and what remains under active follow-up.

  4. 04 Plan

    Enzymes, diabetes, pain, nutrition

    Read this first: enzyme dose, glycaemic plan, opioid taper, dietitian follow-up, and next imaging or surveillance.

Recognised by major UK insurers

BupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealix

Frequently asked

Everything we get asked about surgery for chronic pancreatitis.

  • When is surgery for chronic pancreatitis actually indicated?

    After endoscopic therapy, pain medicine and structured cessation have failed. The classic indications are intractable pain despite optimal medical and endoscopic treatment, a head-dominant mass with duct dilatation, a complication (biliary or duodenal obstruction, pseudocyst), or a suspicion of malignancy that cannot be excluded.

  • Frey, Beger, Whipple or TPIAT - how is the choice made?

    At a pancreas MDT. Head-dominant with dilated duct usually points to Frey or Beger. Whipple where malignancy cannot be excluded or the head is extensively involved. TPIAT is for diffuse small-duct disease with intractable pain in highly selected patients. The operation is chosen by anatomy, disease pattern and expected pain-relief profile.

  • Will surgery make my pain go away?

    Often it improves it substantially - 60–80 percent report meaningful pain reduction at 1 year across published series. It rarely takes pain to zero. A parallel pain-medicine plan and opioid taper is part of the deal.

  • Will I become diabetic?

    Variable. Frey and Beger preserve most of the pancreas and induce diabetes in 0–5 percent. Whipple induces diabetes in 10–20 percent. TPIAT preserves endogenous insulin in around 30–70 percent depending on how many islets can be isolated from the removed pancreas - but the trade-off is a total pancreatectomy and lifelong exocrine insufficiency.

  • How long is the hospital stay and recovery?

    Frey and Beger: 7–10 days in hospital, 6–8 weeks off physical work. Whipple: 10–14 days in hospital, 8–12 weeks off. TPIAT: 14–21 days in hospital and a longer recovery. Enzyme replacement is lifelong.

  • How much does private chronic pancreatitis surgery cost in the UK?

    Frey £28,000–£45,000. Beger £32,000–£52,000. Whipple for CP £45,000–£75,000. TPIAT £90,000–£160,000.

Related treatments

Looking for something else?